Your browser doesn't support javascript.
loading
Cobalamin D Deficiency Identified Through Newborn Screening.
Abu-El-Haija, Aya; Mendelsohn, Bryce A; Duncan, Jacque L; Moore, Anthony T; Glenn, Orit A; Weisiger, Kara; Gallagher, Renata C.
Afiliação
  • Abu-El-Haija A; Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA. ayaaa120@yahoo.com.
  • Mendelsohn BA; Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
  • Duncan JL; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA.
  • Moore AT; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA.
  • Glenn OA; Department of Radiology, University of California, San Francisco, San Francisco, CA, USA.
  • Weisiger K; Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
  • Gallagher RC; Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA. renata.gallagher@ucsf.edu.
JIMD Rep ; 44: 73-77, 2019.
Article em En | MEDLINE | ID: mdl-30097992
ABSTRACT
Cobalamin D deficiency (cblD) is one of the least common cobalamin metabolism disorders. It may result in isolated homocystinuria, isolated methylmalonic aciduria, or combined methylmalonic aciduria and homocystinuria (cblD-combined). Only seven cases of the combined cblD form have been reported to date. Due to the rarity of this disorder, the presentation and symptoms are not well described. We present an eighth case of the cblD-combined subtype, who had a positive newborn screen (NBS) on day of life 3. She was symptomatic and developed lethargy and poor oral intake at 8 days of life. She was treated with 10% dextrose, folinic acid, intramuscular hydroxocobalamin, and betaine. Despite the early initiation of treatment, she developed complications of the disease and was found to have abnormal brain imaging findings at 17 days of age and macular atrophy at 3 months of age and has global developmental delay. We provide detailed description of her presentation, her treatment, and her complications to aid in the understanding of this rare disorder, which is very similar to the more common cobalamin C disorder (cblC).
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: JIMD Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: JIMD Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
...